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Both estrogens and androgens play important parts in
skin and hair physiology, although studies of estrogen
action in human skin have been rather limited. Re-
cently, a second estrogen receptor (b) has been identi-
¢ed in many nonclassical target tissues, including
androgen-dependent tissues. Therefore, we have revis-
ited the role of estrogens in human skin and hair by
comparing the pattern of expression by immunohisto-
chemistry for both estrogen receptors (a and b) and the
androgen receptor. Immunolocalization of androgen
receptors was only seen in hair follicle dermal papilla
cells and the basal cells of the sebaceous gland. Little
speci¢c staining of estrogen receptor a was seen any-
where except the sebaceous gland. In contrast estrogen
receptor b was highly expressed in epidermis, blood
vessels, and dermal ¢broblasts, whereas in the hair folli-
cle it was localized to nuclei of the outer root sheath,
epithelial matrix, and dermal papilla cells. Serial sections
also showed strong nuclear expression of estrogen
receptor b in the cells of the bulge, whereas neither
estrogen receptor a or androgen receptor was ex-
pressed. In the sebaceous gland, estrogen receptor b
was expressed in both basal and partially di¡erentiated
sebocytes in a similar pattern to estrogen receptor a.
There was no obvious di¡erence in the expression of
either estrogen receptor in male or female nonbalding
scalp skin. The results of this immunohistochemical
study propose that estrogen receptor b and not estrogen
receptor a is the main mediator of estrogen action in
human skin and the hair follicle. Further studies with
androgen-dependent skin are required to determine
whether estrogen receptor b has a regulatory role on an-
drogen receptor expression in the hair follicle in parallel
with its role in other androgen-dependent tissues. Key
words: androgen receptor/estrogen receptor/hair follicle/human
skin. JID Symposium Proceedings 8:100 ^103, 2003
ESTROGEN RECEPTORS (ER): ERa AND ERb
S
ince the isolation and cloning of the ER (Greene et al,
1986), it was thought that only a single nuclear ER ex-
isted until a second gene coding for an ERwas cloned
from rat prostate (Kuiper et al, 1996) and human testis
(Mosselman et al, 1996) cDNA libraries. Owing to a sig-
ni¢cant homology with the DNA binding domain of the classi-
cal ER, this second receptor was termed ERb, whereas the
classical ER is now referred to as ERa. The two ER are not gen-
erated from alternate transcription sites of the same gene, as is the
progesterone receptor (Taylor, 2001), but are distinct proteins en-
coded by separate genes located on di¡erent chromosomes. The
ERa and ERb proteins haveE 60% conservation of the residues
in the ligand binding domain, yet each bind 17b-estradiol with
nearly equal a⁄nity and exhibit a very similar binding pro¢le
for a large number of natural and synthetic ligands (Kuiper et al,
1997); however, there are major di¡erences between ERb and
ERa with respect to their tissue distribution (Fisher et al, 1998;
Taylor and Al-Azzawi, 2000), the phenotype of the correspond-
ing knockout mice and their transcriptional activities (Dechering
et al, 2000). Additionally, studies have shown that ERb and ERa
can heterodimerize in vitro, indicating the possibility of coopera-
tive, synergistic, or inhibitory actions between the two receptors
(Cowley et al, 1997; Pettersson et al, 1997). Therefore, the discovery
of ERb has introduced a new level of complexity to the mechan-
ism of estrogen signaling and physiology.
ESTROGENS AND SKIN
The importance of estrogens in the maintenance of human skin is
highlighted by the signi¢cant changes that occur in the skin of
postmenopausal women, which may be reversed with hormone
replacement. Estrogens not only improve collagen content and
quality, they also increase skin thickness and enhance vasculariza-
tion (reviewed Brincat, 2000). Although binding studies have de-
monstrated the presence of estrogen-binding sites in human skin
(Punnonen et al, 1980), immunolocalization of ER has been di⁄-
cult to correlate with those estrogen-binding sites. This has inevi-
tably limited the number of studies on estrogen action in human
skin. Estrogens also play a part in the regulation of the hair cycle
in the rat, where estrogens slow down the moult cycle (Ebling,
1976), whereas in both sexes of mice, topical estradiol maintains
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the hair follicle in telogen, blocking its transition into anagen,
with a resultant inhibition of hair growth (Chanda et al, 2000).
The e¡ects of pregnancy hormones on hair growth are also well
recognized, with postpartum alopecia a striking phenomenon
seen in women. During pregnancy there is an increase in the
number of hairs in anagen, which leads to an increased number
entering telogen postpartum resulting in an increase in hair
shedding (Lyn¢eld, 1960).
Estrogens are also powerful suppressors of androgen-stimu-
lated sebaceous activity in doses markedly lower than those
required for anti-androgens (Ebling, 1974), the mechanism of ac-
tion of estradiol in the sebaceous gland was concluded to be
distinct from that of an anti-androgen (Ebling, 1974) suggesting
that estrogens act via a non-androgen receptor (non-AR)-depen-
dent pathway.
INTERACTION OF ESTROGENS ANDANDROGENS
The presence of ERb in the prostate and testis, classical andro-
gen-target tissues, and experiments with ER knockout mice have
clearly indicated that ERb plays an important part in prostate and
testis development (Gustafsson, 2000; Makinen et al, 2001), which
is supported by the fact that prostate cancer often responds favor-
ably to estrogen treatment due to interaction with androgen-de-
pendent signaling pathways. Studies with ERa, ERb and AR
knockout mice (termed ERKO, BERKO, and ARKO, respec-
tively) have shown that the interaction of ERa, ERb, and AR
is of the utmost importance in the regulation of some tissues
(Krege et al, 1998). In addition there are numerous reports that
estrogen and androgen metabolites can interact with both recep-
tor subtypes. For example, androst-5-ene-3b, 17b-diol a metabo-
lite of dehydroepiandrosterone can interact presumably with
both ERa and ERb in MCF7 human breast cancer cells (Adams
et al, 1981), whereas 5a-androstane-3b, 17b-diol, a metabolite of
5a-dihydrotestosterone interacts with ERb in the prostate (DebeŁ
et al, 1979). Taken together, this indicates that the role of estrogens
and androgens in the control of skin physiology and pathophy-
siology are probably interdependent (see Fig 1).
Although it is well established that androgens have an impor-
tant role in the regulation of human hair growth (reviewed
Randall, 2000), the exact interaction of estrogens and androgens
is at present unclear. The complexity of androgen action on
human hair growth is highlighted by the contradictory e¡ects of
androgens illustrated in individuals with androgenic alopecia.
Such a biologic paradox implies that there are other regulatory
factors at work. The role of ERb in regulating the androgen-de-
pendent prostate suggests that this may have a parallel role in
other androgen-dependent tissues, including the human hair
follicle.
EXPERIMENTAL DESIGN
As the interactions between estrogens and androgens in human
skin are unclear it is essential to show that human skin has the
necessary machinery to mediate both estrogenic and androgenic
signals prior to investigations into the interactions of these steroid
hormones. To determine whether the presence of both ER is
important in human skin, or whether one ER predominates, we
have compared the distribution of ERa and ERb in human scalp
skin.We have examined skin from similar sites of both sexes to
establish whether there is a di¡erence in the expression of ER
between males and females. As there is strong evidence from
studies using androgen-dependent tissues such as the prostate that
ERb can regulate AR production, the relative expression of ERb
and AR may also be of signi¢cance in the hair follicle, particu-
larly those that are androgen dependent. Therefore, we have also
compared the distribution of AR in the same skin samples.
MATERIALS ANDMETHODS
Normal human skin samples from nonbalding areas of scalp were obtained
from patients at the time of surgery. Small pieces of skin were ¢xed in for-
mol saline for a ¢xed period of 24 h before processing into para⁄n wax.
The nonbalding scalp of a total of 12 patients (six male and six female)
were examined for the distribution of steroid receptors. Serial sections (4
mm) were mounted on to silane-coated slides and allowed to dry at 371C,
before incubating with either monoclonal mouse anti-bovine ERa (1 : 50)
polyclonal rabbit anti-rat ERb antibody (1 : 50) (Upstate Biotechnology,
Lake Placid, NY), or a monoclonal antibody for the AR (1 : 25)
(Novocastra, New Castle-upon-Tyne, U.K.), as described previously
(Taylor and Al-Azzawi, 2000) and according to the manufacturers’
instructions. Brie£y, sections were dewaxed, rehydrated, and endogenous
peroxidase, biotin, and nonspeci¢c sites blocked with standard procedures
before incubation with primary antibody at 41C for 18 h. The antibody^
antigen complex was ampli¢ed using horseradish peroxidase-linked
avidin^biotin complexes (Vector Laboratories, Peterborough U.K.) after
biotinylated secondary anti-rabbit and anti-mouse IgG incubation.
Visualization was achieved with Cu2þ enhanced diaminobenzidine and
light hematoxylin counterstaining, before mounting in XAM mounting
medium (BDH, Poole, Dorset, U.K.). Speci¢city of immunostaining was
con¢rmed using molar equivalents of rabbit IgG (ERb) or mouse IgG
(ERa, AR). Additionally, several control sections were produced by
omission of the primary antibody. Positive control tissue included human
ovary and human breast carcinoma for expression of ERa, human prostate
for ERb, and human testis for AR antigens.
RESULTS
ERb was the predominant steroid receptor in both male and
female human nonbalding scalp skin. In the hair follicle, ERb
was immunolocalized to the cell nuclei of the outer root sheath,
epithelial matrix, and dermal papilla cells (see Fig 2). This was in
contrast to ERa, which did not stain the hair follicle cells, and
AR, which only stained dermal papilla cells. Serial sections of
one follicle clearly showed ERb strongly expressed in the bulge,
whereas there was no staining for either ERa or AR. ERbwas
also expressed in the nuclei and cell membranes of the partially
di¡erentiated sebocytes (see Fig 3); a similar pattern of nuclear
and membrane staining was seen with ERa. In the epidermis,
strong ERb expression was seen in the keratinocytes of the stra-
tum basale and stratum spinosum, whereas the cells of the
stratum granulosum were less immunoreactive and the stratum
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Figure1. Hypothetical model for the interdependence of estrogens
and androgens in human skin. Aromatase activity can be upregulated
by either testosterone or 5a-dihydrotestosterone binding to AR, thereby
increasing the availability of 17b-estradiol. 5a-dihydrotestosterone can be
3b reduced by 3b-hydroxsteroid dehydrogenase (3b-HSD) to produce
5a-androstane-3b,17b-diol. Both 17b-estradiol and 5a-androstane-3b,17b-
diol can bind to ERb, which can downregulate AR expression. Blocking
the production of 5a-dihydrotestosterone may inadvertently upregulate
AR by (i) downregulating aromatase via AR inactivation, and (ii) inacti-
vation of ERb by limiting the availability of 5a-androstane-3b,17b-diol.
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corneum was devoid of immunoreactivity (see Fig 4). By
contrast, there was no expression of ERa or AR in these
structures. In addition to the staining seen in the epidermis, the
underlying ¢broblasts of the papillary dermis also showed
strong nuclear expression of ERb. There was no obvious
di¡erence in the expression patterns of either ER in male or
female skin.
DISCUSSION
Studies of estrogen action in human skin and hair have been
limited to some extent because immunohistochemical expression
of ER has been di⁄cult to demonstrate, even though radio-la-
beled estradiol was known to bind to structures within skin and
hair. The results of the present immunohistochemical study
demonstrate that ERb and not ERa is the main mediator of
estrogen action in human skin and the hair follicle. The inability
to demonstrate ER staining in human skin by immunohisto-
chemistry is hardly surprising as until recently only one ERwas
thought to exist, i.e., ERa; however, these data are contrasted by
studies in the mouse where ERa and not ERbwas identi¢ed in
hair follicles (Chanda et al, 2000). These apparent inconsistencies
between ERa and ERb expression in human and mouse need to
be interpreted with care as the expression of ERb protein also
di¡ers markedly in other human tissues when compared with
the mouse or rat (Fisher et al, 1998; Taylor and Al-Azzawi, 2000).
Interestingly, we have recently reported that the distribution of
ERb in red deer skin is also in complete contrast to that de-
scribed in human skin (Thornton et al, 2000). Although ERb
was strongly expressed in the blood vessels of red deer skin in
common with human skin, there was no expression of ERb in
epidermis, dermis, or the pilosebaceous unit (Thornton et al,
2000). These observations are noteworthy as it may signify that
ERb plays a unique part in human skin and that the predomi-
nant mediator of estrogen action in other mammals is the ERa.
Our observed AR expression in nonbalding scalp dermal
papilla cells supports the observations of AR expression from
previous studies (Choudry et al, 1992; Randall et al, 1992; Hibberts
et al, 1998). Androgens, such as testosterone and 5a-dihydrotestos-
terone, are not required for scalp hair growth, as patients with
AR defects have good hair growth; however, androgens, particu-
larly 5a-dihydrotestosterone appear to be a requirement for
androgenetic alopecia (Sawaya, 2000).This leads to the hypothesis
that estrogens or androgenic metabolites might be more impor-
tant molecules for hair growth control in the human scalp. Clues
Figure 2. Immunohistochemical localization of ERb to human
occipital scalp hair follicles (original magni¢cation 250). Bound
antibodies were visualized with diaminobenzidine and is seen as brown
staining. Sections were counterstained with hematoxylin (blue nuclei).
ERbwas widely expressed in the hair follicle bulb. Speci¢c nuclear stain-
ing was seen in the mesenchymal dermal papilla and epithelial outer root
sheath and hair matrix cells.
Figure 3. Immunohistochemical localization of ERb to human
occipital scalp sebaceous glands (original magni¢cation128).
Bound antibodies visualized with diaminobenzidine are seen as brown nu-
clear staining. Sections were counterstained with hematoxylin (blue nu-
clei). ERbwas widely expressed in the sebaceous gland, particularly in the
partially di¡erentiated sebocytes. Staining was not restricted to the nucleus,
but was also present in the cytoplasm, particularly concentrated around the
cell membrane.
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from other androgen-target tissues such as the prostate in the
ERb knockout mice, which shows a distinct hyperproliferation,
suggests that ERb is important in controlling prostate growth,
probably by downregulating AR expression (Gustafsson, 2000).
By extension, an important role for ERb in the human hair
follicle may be to regulate androgen-dependent hair growth by
modulating AR expression or androgen signaling pathways. In
this respect, it is noteworthy that ¢nasteride, an inhibitor of
5a-reductase, has only been shown to be e¡ective in men and
not postmenopausal women to treat androgenetic alopecia (Price,
2000). Also other recent studies by Lachgar et al (1999) have
shown that ¢nasteride upregulates aromatase expression in
cultured scalp dermal papilla cells, indicating that ¢nasteride
might have an estrogen promoting e¡ect because it increases the
amount of testosterone that is converted to 17b-estradiol (Fig 1).
Furthermore, Sawaya (2000) has reported that there are di¡er-
ences in aromatase expression in scalp follicles taken from men
and women and also between occipital and frontal follicles. That
study showed higher levels of aromatase activity in occipital scalp
follicles compared with frontal scalp follicles in both sexes;
however, aromatase activity was 6-fold higher in frontal hair
follicles of females compared with males. Interestingly, the
expression of aromatase in human genital skin ¢broblasts has
been shown to be androgen dependent, with much lower levels
of expression in cells from patients with androgen insensitivity
syndromes (Stillman et al, 1990). In addition, androgens can sig-
ni¢cantly increase aromatase activity in cultured genital skin
¢broblasts, which can be blocked by an anti-androgen (Stillman
et al, 1991), demonstrating that the response is mediated via the
AR.
In order to understand the e¡ects of reproductive hormones on
skin aging, skin cancer, hair growth, and loss, there is an over-
whelming need to widen our understanding of the physiology
and interaction of steroid hormones and their receptors in human
skin. Clearly further studies of the role of ERb in human skin
are warranted, particularly in relation to the expression of AR
and modulation of androgen action pathways in the pilose-
baceous unit. Studies such as those suggested could contribute
to an understanding of the paradoxical, site-dependent, e¡ects of
androgens on hair growth.
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Figure 4. Immunohistochemical localization of ERb to human oc-
cipital scalp skin (original magni¢cation100). Immunoreactive
ERbvisualized with diaminobenzidine appears as brown nuclear staining,
whereas nuclei counterstained with hematoxylin appear blue. Strong ERb
staining was restricted to the keratinocytes of the stratum basale and stra-
tum spinosum, whereas the cells of the stratum granulosum were less
immunoreactive. The stratum corneum was devoid of immunoreactivity
for ERb. In addition to the staining seen in the epidermis, the underlying
¢broblasts of the papillary dermis also showed strong nuclear staining
for ER.
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